‘Serious’ polarization of R&D investment among innovative pharmaceutical companies

Published: 2017-10-27 15:42:08

Updated: 2017-10-27 15:42:08

It was criticized polarization of R&D investments was getting intensified among innovative pharmaceutical companies certified to have excellent new drug development and overseas expansion capabilities.

While there is a company spending more money into R&D than sales they make, there were companies poor in investing money into R&D with a R&D/sales ratio less than 5%.

Yakup Shinmoon(www.yakup.c...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.